Home » Topics » Collaboration, BioWorld Science

Collaboration, BioWorld Science
RSS

Theraclone and Pfizer to codevelop antibodies against infectious disease and cancer targets

Jan. 21, 2011

Evotec and Takeda Cambridge join to identify GPCR and protease modulators

Jan. 21, 2011

Harbor BioSciences licenses three compounds to CIPI in China

Jan. 20, 2011

PROLOR and Yeda sign agreement for reversible PEGylation technology

Jan. 20, 2011

Johns Hopkins Brain Science Institute and Ortho-McNeil-Janssen enter collaboration

Jan. 20, 2011

Ironwood Pharma and Protagonist Therapeutics join to develop new peptide therapeutics

Jan. 20, 2011

Chugai grants Circadian Technologies global license to VEGF-D program

Jan. 19, 2011

Merck Serono and Domain Therapeutics join to develop agents for Parkinson's disease

Jan. 18, 2011

Galapagos provides update on arthritis alliance with GSK

Jan. 18, 2011

Epizyme and GSK join to develop agents targeting histone methyltransferases

Jan. 18, 2011

Popular Stories

Today's news in brief
BioWorld
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026